rs140769107
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003119.4(SPG7):c.2275G>A(p.Ala759Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000781 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPG7 | NM_003119.4 | c.2275G>A | p.Ala759Thr | missense_variant | 17/17 | ENST00000645818.2 | NP_003110.1 | |
SPG7 | XM_047434540.1 | c.961G>A | p.Ala321Thr | missense_variant | 9/9 | XP_047290496.1 | ||
SPG7 | NM_001363850.1 | c.*53G>A | 3_prime_UTR_variant | 18/18 | NP_001350779.1 | |||
SPG7 | XM_047434537.1 | c.*53G>A | 3_prime_UTR_variant | 13/13 | XP_047290493.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPG7 | ENST00000645818.2 | c.2275G>A | p.Ala759Thr | missense_variant | 17/17 | NM_003119.4 | ENSP00000495795.2 |
Frequencies
GnomAD3 genomes AF: 0.000558 AC: 85AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000561 AC: 141AN: 251324Hom.: 0 AF XY: 0.000611 AC XY: 83AN XY: 135880
GnomAD4 exome AF: 0.000805 AC: 1176AN: 1461520Hom.: 0 Cov.: 31 AF XY: 0.000776 AC XY: 564AN XY: 727052
GnomAD4 genome AF: 0.000551 AC: 84AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000591 AC XY: 44AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 06, 2022 | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in one individual with later onset spastic paraplegia who also carried a truncating variant in this gene (PMID: 21623769). -Computational tools predict that this variant is not damaging. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 01, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2022 | SPG7: PM2:Supporting, BP4 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 17, 2023 | Reported as heterozygous variant in an individual with sporadic adult-onset pure spastic paraparesis; however, a second variant in SPG7 was not identified (Brugman et al., 2008); Reported with a pathogenic variant in a patient with adult-onset spastic paraplegia and ataxia, but it is not known if the variants occurred on the same (in cis) or on different (in trans) chromosomes (Schlipf et al., 2011); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 18799786, 21623769) - |
Hereditary spastic paraplegia 7 Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
Hereditary spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Apr 07, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at